Form 4 Filing for ACTUATE THERAPEUTICS, INC.

This filing details a Form 4 submission for ACTUATE THERAPEUTICS, INC. by reporting owner TODD S THOMSON. On May 21, 2026, Mr. Thomson acquired 15,000 Stock Options with a transaction price of $0.00 per share. These options are exercisable and will vest in full on the anniversary of the grant date, expiring on May 21, 2036. The underlying security is Common Stock, with 15,000 shares. Mr. Thomson is a 10% owner, a director, and an officer of Kairos Venture Investments, LLC. His board position at Actuate Therapeutics, Inc. is as a representative of funds managed by KVI, and these funds have an indirect pecuniary interest in the granted securities.